July 31st, 2020
3:00pm - 3:45pm ET
ACS CAN → Mark Fleury, Devon Adams, Kelly Durden
MITRE → Salim Semy, Jennifer Holmes, Zach Lister, Rob Dingwell, Caroline Potteiger
Cancer Insights → Sharon Alford, Tarun Kumar
- Kelly → touch base with Robin about connection with the Grady Health System.
- Sharon → make the introduction between ZS Associates and this team.
- Caroline Potteiger → send Confluence permission information to the team.
- All → brainstorm tasks for each Phase 1a bucket and send to Caroline.
Discussion notes in blue. Decisions in green. Action items in red.
Planned Agenda Topics
- <Hold for hot topics from project team>
- Mark will be out next week.
- Engagement Update
- Epic – very interested, seemed willing to partner if we identify a health center for Phase 1
- Epic can give feedback on the health center and if they have the ability to work well in this project.
- For the grant ACS CAN is applying to, an ideal partner health system would be in a redline area.
- The Grady Health System in Atlanta is one they are looking at. They use Epic and ACS CAN has a lot of projects with them.
- Kelly will touch base with Robin to see where the connections with Grady are and if they're willing to partner if offered some money.
- Caroline will be sending out a list of health systems we are talking with to Epic. Leave Grady off the list for now, until contact is made on our end first.
- The fact that Epic is willing to partner on this use case is a compelling point for health systems to become involved.
- As we iterate on the minimal eligibility criteria, Epic could add it to their system.
- TrialJectory – meeting scheduled for August 13th
- Massive Bio – willing to provide a handful of patient records, has to look into de-identification process more
- Seline offered to reach out to St. Charles.
- CitiusTech - has expressed interest
- Elsevier - has expressed interest
- Elsevier has the ViaOncology Pathways tool and is looking at ways to bring matching capabilities into the tool. This could include a branch in the pathway for when it is time to start looking for clinical trials.
- They are discussing internally about this project.
- Would act similar to an EHR.
- Other updates?
- Flatiron - reached out to Mark and wants to learn more.
- MITRE has been interacting with them on the Pathways and Prior Auth use cases. Make sure everyone is kept in the loop.
- Cancer Support Community - reached out and spoke to Mark.
- They are an advocation group. Not a great fit at this time, no immediate next steps.
- NCI - expressed interest in learning more and would act as a matching service partner.
- However, NCI matching would only focus on NCI sponsored trials.
- BeTheMatch - couldn't find bandwidth to work on this project this year.
- UCSF - Elly, Adam, and Lisa will be speaking about a UCSF partnership in August.
- ZS Associates - Cancer Insights has worked with them. Sharon will make an introduction and see if there is an intersection between their work and ours.
- Phase 0 update
- Mike gave us more administrative access, last step is to label the trials
- Add more trials?
- Phase 1 update
- Planning in progress
- Caroline to showcase Private Confluence page as a way to collaborate
- Looks good for now. Caroline to send permission information to everyone so they can experiment with Confluence.
- Proposed tasks for Phase 1a
- Tarun and Caroline came up with some "buckets" of tasks for Phase 1a and a few sub-tasks under each bucket
- Review and add tasks?
- 1A Protocol and Pilot Process
- Draft study protocol and IRB submission
- Process of de-identification
- Plan out recruitment of patients – Mark to help?
- Create a 1-pager targeted towards patients?
- Are patients needed for this phase? Or just data?
- If it's just data, all we need is access.
- Option 1 - Cancer Insights patients can get their data and share it with us.
- Would need a waiver of consent from the IRB to share this data. Must be de-identified.
- Problem is that patients are giving us data, but we're not really giving much back.
- Option 2 - find sources of existing data.
- BreastCancerTrials.org may have data we can use.
- Ciitizen - could be a source of data. Mark has spoken to them.
- MITRE has also had discussions with Anil Sethi when this project was just beginning. We could revisit this.
- Option 3 - find volunteers willing to share data.
- ACS CAN has a lot of volunteers who would most likely be willing to share data.
- However, to use ACS CAN's name, there would be many internal hoops to jump through, which would take a lot of time.
- Plan out onboarding of patients
- Generate mCODE records for these patients
- PCT Technical Readiness for 1A
- Cancer Insights Integration
- Map Cancer Insights data model to generate mCODE
- Address gaps using FHIR Questionnaire
- Create an agnostic interface
- Integration with PCT component
- Standards Documentation
- Adjust documentation to be more trial matching service agnostic and patient portal agnostic
- Develop a FHIR Implementation Guide for mCODE-enabling matching services
- mCODE-enable Matching Services Suggestion: We may roll it into PCT Technical Readiness for 1A
- Create Sandbox
- Map matching service to mCODE